Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

Volume: 20, Issue: 10, Pages: 1145 - 1156
Published: Oct 1, 2018
Abstract
To review the evidence for the effectiveness and cost-effectiveness of cancer risk management interventions for BRCA carriers.Comparative effectiveness and cost-effectiveness analyses were identified by searching scientific and health economic databases. Eligible studies modeled the impact of a cancer risk management intervention in BRCA carriers on life expectancy (LE), cancer incidence, or quality-adjusted life years (QALYs), with or without...
Paper Details
Title
Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review
Published Date
Oct 1, 2018
Volume
20
Issue
10
Pages
1145 - 1156
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.